These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32352602)

  • 21. The anti-nephritic activity of a polysaccharide from okra (Abelmoschus esculentus (L.) Moench) via modulation of AMPK-Sirt1-PGC-1α signaling axis mediated anti-oxidative in type 2 diabetes model mice.
    Liao Z; Zhang J; Wang J; Yan T; Xu F; Wu B; Xiao F; Bi K; Niu J; Jia Y
    Int J Biol Macromol; 2019 Nov; 140():568-576. PubMed ID: 31442509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice.
    Jiang M; Yang Z; Lyu L; Shi M
    J Diabetes Complications; 2024 Feb; 38(2):108687. PubMed ID: 38266571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
    Malek V; Sharma N; Sankrityayan H; Gaikwad AB
    Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.
    Wang Q; Ren D; Li Y; Xu G
    Cell Cycle; 2019; 18(6-7):696-707. PubMed ID: 30784349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation.
    Chao J; Guo Y; Chao L
    Oxid Med Cell Longev; 2018; 2018():4138560. PubMed ID: 30622668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
    Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
    BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
    Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
    Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
    Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy.
    Zhou T; He X; Cheng R; Zhang B; Zhang RR; Chen Y; Takahashi Y; Murray AR; Lee K; Gao G; Ma JX
    Diabetologia; 2012 Jan; 55(1):255-66. PubMed ID: 22016045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes.
    Abreu ICME; Albuquerque RCMF; Brandão ABP; Barssotti L; de Souza LB; Ferreira FG; Oliveira LCG; Yokota R; Sparvoli LG; Dias DDS; Salgado MAC; Taddei C; De Angelis K; Casarini DE; Cunha TS
    Life Sci; 2022 Jul; 301():120616. PubMed ID: 35533758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
    Lo CS; Shi Y; Chenier I; Ghosh A; Wu CH; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Diabetes; 2017 Jul; 66(7):1964-1978. PubMed ID: 28424160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.
    Liu X; Zhang B; McBride JD; Zhou K; Lee K; Zhou Y; Liu Z; Ma JX
    Diabetes; 2013 Dec; 62(12):4228-38. PubMed ID: 23884893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
    Wang Y; Fang Q; Jin Y; Liu Z; Zou C; Yu W; Li W; Shan X; Chen R; Khan Z; Liang G
    Br J Pharmacol; 2019 Jul; 176(14):2642-2657. PubMed ID: 30959575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous kallikrein protects against diabetic nephropathy.
    Liu W; Yang Y; Liu Y; Lu X; Guo S; Wu M; Wang M; Yan L; Wang Q; Zhao X; Tong X; Hu J; Li Y; Hu R; Stanton RC; Zhang Z
    Kidney Int; 2016 Nov; 90(5):1023-1036. PubMed ID: 27546607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
    J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.
    Liu D; Wu M; Li L; Gao X; Yang B; Mei S; Fu L; Mei C
    Br J Nutr; 2018 Jan; 119(1):22-29. PubMed ID: 29208058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acarbose Protects Glucolipotoxicity-Induced Diabetic Nephropathy by Inhibiting Ras Expression in High-Fat Diet-Fed db/db Mice.
    Hung TW; Yu MH; Yang TY; Yang MY; Chen JY; Chan KC; Wang CJ
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.